
News|Articles|August 21, 2015
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types
Author(s)Suresh S. Ramalingam
Key Takeaways
- Immunotherapy offers significant advantages over traditional cancer treatments but presents unique toxicity profiles requiring distinct management strategies.
- Immune-related toxicities can affect various organ systems, necessitating vigilant monitoring and intervention by oncologists.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer
2
SHARON Trial Offers a Potential Approach for Advanced Pancreatic Cancer
3
FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers
4
FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia
5





